MergerLinks - David A. Ricks

target

Loxo Oncology

bidder

Eli Lilly And Company

£6,281m

55 dealmakers

United States

Pharmaceuticals

MajorityAcquisitionTender OfferPublicDomesticPrivate Equity

target

Dermira

bidder

Eli Lilly And Company

£838m

41 dealmakers

United Kingdom

Biotechnology

AcquisitionVenture CapitalPrivate EquityMinorityPrivate

target

IMMUNOCORE

bidder

JDRF

£101m

30 dealmakers

United States

Biotechnology

AcquisitionDomesticMajorityPrivatePrivate Equity

target

Disarm Therapeutics

bidder

Eli Lilly And Company

£103m

7 dealmakers

United States

Biotechnology

PrivatePrivate EquityMajorityVenture CapitalDomesticAcquisition

target

Sigilon Therapeutics

bidder

BLACKROCK

£65m

8 dealmakers

Netherlands

Biotechnology

Private EquityPrivateAcquisitionMinorityCross Border

target

Merus B.v.

bidder

Eli Lilly And Company

£14m

4 dealmakers

United States

Biotechnology

AcquisitionPrivateMajorityDomestic

target

Protomer Technologies

bidder

Eli Lilly And Company

£722m

15 dealmakers

United States

Pharmaceuticals

DomesticAcquisitionMajorityPrivate

target

BAQSIMI

bidder

Amphastar Pharmaceuticals

£866m

7 dealmakers

United States

Biotechnology

PrivateDomesticAcquisitionMajority

target

VERSANIS

bidder

Eli Lilly And Company

£1,472m

26 dealmakers

United States

Biotechnology

DomesticAcquisitionMajorityPublic

target

Point Biopharma

bidder

Eli Lilly And Company

£1,152m

40 dealmakers

United States

Biotechnology

Cross BorderVenture CapitalPrivate EquityMinorityAcquisitionPrivate

target

Crossbow Therapeutics

bidder

Mirae Asset Venture Investment

£62m

9 dealmakers